dc.contributor.author | Alvear-Sedan, Ciro César | spa |
dc.contributor.author | Barboza-Ubarnes, Miriam | spa |
dc.contributor.author | Grijalba-Romero, Miguel Ángel | spa |
dc.date.accessioned | 2013-01-15 00:00:00 | |
dc.date.available | 2013-01-15 00:00:00 | |
dc.date.issued | 2013-01-15 | |
dc.identifier.issn | 2215-7840 | |
dc.identifier.uri | https://hdl.handle.net/11227/12954 | |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.publisher | Universidad de Cartagena | spa |
dc.relation.ispartofjournal | Revista Ciencias Biomédicas | spa |
dc.rights | Revista Ciencias Biomédicas - 2020 | spa |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | spa |
dc.source | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2765 | spa |
dc.subject | Enfermedades Metabólicas | spa |
dc.subject | Mucopolisacaridosis | spa |
dc.subject | Diagnóstico precoz | spa |
dc.subject | Terapia enzimática | spa |
dc.subject | | spa |
dc.title | Experiencia clínica y bioquímica de las mucopolisacaridosis en Cartagena de Indias, Colombia | spa |
dc.type | Artículo de revista | spa |
dc.title.translated | Experiencia clínica y bioquímica de las mucopolisacaridosis en Cartagena de Indias, Colombia | eng |
dc.identifier.doi | 10.32997/rcb-2013-2765 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
dc.identifier.eissn | 2389-7252 | |
dc.identifier.url | https://doi.org/10.32997/rcb-2013-2765 | |
dc.relation.bitstream | https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2765/2313 | |
dc.relation.citationedition | Núm. 1 , Año 2013 | spa |
dc.relation.citationendpage | 158 | |
dc.relation.citationissue | 1 | spa |
dc.relation.citationstartpage | 152 | |
dc.relation.citationvolume | 4 | spa |
dc.relation.references | Alvear C. Bioquímica humana: de las bases a la clínica. Cartagena: Editorial Universitaria de Cartagena; 2007. p. 583-585. | spa |
dc.relation.references | Muenzer J. The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations.J Pediatr. 2004; 144(5 Suppl):S27-34. | spa |
dc.relation.references | Barrera LA. Estudios bioquímicos de los errores innatos del metabolismo en Colombia, durante dos décadas. Revista Academia Colombiana de Ciencias. 2009; 33(128):377-394. | spa |
dc.relation.references | Neufeld EF, Muenzer J. The Mucopolysaccharidoses. En Scriver CR, Beaudet, AL, Sly WS, Valle D, Childs B, Kinzler KW y Vogelstein B. (eds.), Metabolic and Molecular Basis of Inherited Disease. SanFrancisco: MacGraw-Hill; 2001; pp 3421-3452. | spa |
dc.relation.references | Wrait JE. The first 5 years of clinical experience with Laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert OpinPharmacother. 2005; 6: 489-50. | spa |
dc.relation.references | Gutiérrez-Solana L.G. Avances en el tratamiento en las enfermedades lisosomales en la infancia. Rev. Neurol. 2006; 43(Supl 1): S137-144. | spa |
dc.relation.references | Pastores GM., Barnett NI. Current and emerging therapies for the lysosomal storage disorders. Expert. Opin. Emerg. Drug. 2005; 10: 891-902. | spa |
dc.relation.references | Lankester B., Whitehouse M., Gargan M. Morquio syndrome. Curr.Orthopaedics.2006; 20:128-131. | spa |
dc.relation.references | Desnick RJ. Enzyme replacement and enhancement therapies for lysosomal diseases.J. Inherit. Metab. Dis. 2004; 27: 385-410. | spa |
dc.relation.references | Giugliani R., Harmatz P., Wraith J. Management Guidelines for Mucopolysaccharidosis VI. Pediatrics. 2007; 120(2):405-418. | spa |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/article | spa |
dc.type.local | Journal article | eng |